The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 179,149 | 16,743 | SH | SOLE | 16,743 | 0 | 0 | |||
| ALLAKOS INC | COM | 01671P100 | 67,457 | 24,710 | SH | SOLE | 24,710 | 0 | 0 | |||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | 205,436 | 7,353 | SH | SOLE | 7,353 | 0 | 0 | |||
| BERKSHIRE HATHAWAY INC DEL | CL B NEW | 084670702 | 369,293 | 1,035 | SH | SOLE | 1,035 | 0 | 0 | |||
| COMPASS THERAPEUTICS INC | COM | 20454B104 | 67,806 | 43,465 | SH | SOLE | 43,465 | 0 | 0 | |||
| HARPOON THERAPEUTICS INC | COM NEW | 41358P205 | 129,291 | 13,176 | SH | SOLE | 13,176 | 0 | 0 | |||
| LEXEO THERAPEUTICS INC | COM | 52886X107 | 138,476 | 10,319 | SH | SOLE | 10,319 | 0 | 0 | |||
| MOLECULAR TEMPLATES INC | COM NEW | 608550208 | 510,510 | 136,866 | SH | SOLE | 136,866 | 0 | 0 | |||
| REZOLUTE INC | COM NEW | 76200L309 | 1,309,075 | 1,318,967 | SH | SOLE | 1,318,967 | 0 | 0 | |||
| SAVARA INC | COM | 805111101 | 1,661,173 | 353,441 | SH | SOLE | 353,441 | 0 | 0 | |||
| SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 628,144 | 1,322 | SH | SOLE | 1,322 | 0 | 0 | |||
| XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | 13,258,512 | 5,641,920 | SH | SOLE | 5,641,920 | 0 | 0 | |||